scholarly journals Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States

2021 ◽  
pp. 1-12
Author(s):  
Michael S Blaiss ◽  
J Allen Meadows ◽  
Shengsheng Yu ◽  
Dan R Robison ◽  
Steve L Hass ◽  
...  
Keyword(s):  
United States ◽  
Economic Burden ◽  
Peanut Allergy ◽  
Pediatric Patients ◽  
The United States

scholarly journals PIH15 COMORBIDITY AND ECONOMIC BURDEN OF PEANUT ALLERGY IN PRIVATELY-INSURED PEDIATRIC PATIENTS IN THE UNITED STATES

2019 ◽  
Vol 22 ◽  
pp. S185
Author(s):  
S. Tilles ◽  
C. Birchwood ◽  
D.R. Robison ◽  
V. Damle ◽  
K.E. Norrett ◽  
...  
Keyword(s):  
United States ◽  
Economic Burden ◽  
Peanut Allergy ◽  
Pediatric Patients ◽  
The United States ◽  
Privately Insured

The economic burden of vertigo and dizziness in the United States

2020 ◽  
pp. 1-10
Author(s):  
Jeremy S. Ruthberg ◽  
Chandruganesh Rasendran ◽  
Armine Kocharyan ◽  
Sarah E. Mowry ◽  
Todd D. Otteson
Keyword(s):  
United States ◽  
Health Care ◽  
Economic Burden ◽  
Clinical Characteristics ◽  
Care Service ◽  
Adult Population ◽  
Health Care Service ◽  
The United States ◽  
Medical Expenditures ◽  
Limited Information

BACKGROUND: Vertigo and dizziness are extremely common conditions in the adult population and therefore place a significant social and economic burden on both patients and the healthcare system. However, limited information is available for the economic burden of vertigo and dizziness across various health care settings. OBJECTIVE: Estimate the economic burden of vertigo and dizziness, controlling for demographic, socioeconomic, and clinical comorbidities. METHODS: A retrospective analysis of data from the Medical Expenditures Panel Survey (2007–2015) was performed to analyze individuals with vertigo or dizziness from a nationally representative sample of the United States. Participants were included via self-reported data and International Classification of Diseases, 9th Revision Clinical Modification codes. A cross-validated 2-component generalized linear model was utilized to assess vertigo and dizziness expenditures across demographic, socioeconomic and clinical characteristics while controlling for covariates. Costs and utilization across various health care service sectors, including inpatient, outpatient, emergency department, home health, and prescription medications were evaluated. RESULTS: Of 221,273 patients over 18 years, 5,275 (66% female, 34% male) reported either vertigo or dizziness during 2007–2015. More patients with vertigo or dizziness were female, older, non-Hispanic Caucasian, publicly insured, and had significant clinical comorbidities compared to patients without either condition. Furthermore, each of these demographic, socioeconomic, and clinical characteristics lead to significantly elevated costs due to having these conditions for patients. Significantly higher medical expenditures and utilization across various healthcare sectors were associated with vertigo or dizziness (p <  0.001). The mean incremental annual healthcare expenditure directly associated with vertigo or dizziness was $2,658.73 (95% CI: 1868.79, 3385.66) after controlling for socioeconomic and demographic characteristics. Total annual medical expenditures for patients with dizziness or vertigo was $48.1 billion. CONCLUSION: Vertigo and dizziness lead to substantial expenses for patients across various healthcare settings. Determining how to limit costs and improve the delivery of care for these patients is of the utmost importance given the severe morbidity, disruption to daily living, and major socioeconomic burden associated with these conditions.

scholarly journals Clinical and Economic Burden of Patients with Uncontrolled Severe Asthma with Low Blood Eosinophil Levels in the United States

2021 ◽  
Vol 147 (2) ◽  
pp. AB47
Author(s):  
Laren Tan ◽  
Joan Reibman ◽  
Chris Ambrose ◽  
Yen Chung ◽  
Pooja Desai ◽  
...  
Keyword(s):  
United States ◽  
Severe Asthma ◽  
Economic Burden ◽  
The United States ◽  
Blood Eosinophil

Epidemiologic and Economic Burden of Achalasia in the United States

2021 ◽  
Author(s):  
Charles E. Gaber ◽  
Swathi Eluri ◽  
Cary C. Cotton ◽  
Paula D. Strassle ◽  
Tim M. Farrell ◽  
...  
Keyword(s):  
United States ◽  
Economic Burden ◽  
The United States
Sign in / Sign up

Export Citation Format

Share Document